Bio-Rad Laboratories (BIO-B) Income from Continuing Operations (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Income from Continuing Operations data on file, last reported at 527100000.0 in Q1 2026.

• Income from Continuing Operations for Q1 2026 came in at 527100000.0, down 923.59% year-over-year; the trailing twelve-month figure through Mar 2026 was 168800000.0 (up 107.8% YoY), and the FY2025 annual result was 759900000.0, up 141.2% from the prior year.
• Income from Continuing Operations declined to 527100000.0 in Q1 2026 per BIO-B's latest filing, from 720000000.0 in the prior quarter.
• Over five years, Income from Continuing Operations peaked at 827814000.0 in Q4 2022 and troughed at 3367315000.0 in Q1 2022.
• A 5-year average of 345653882.35 and a median of 64000000.0 in 2025 frame the typical range for Income from Continuing Operations.
• The sharpest annual moves came in 2024 and 2026: Income from Continuing Operations surged 514.75% in 2024, then tumbled 923.59% in 2026.
• A 5-year view of Income from Continuing Operations shows it stood at 827814000.0 in 2022, then slumped by 57.75% to 349736000.0 in 2023, then slumped by 304.67% to 715800000.0 in 2024, then jumped by 200.59% to 720000000.0 in 2025, then sank by 173.21% to 527100000.0 in 2026.
• Business Quant data shows BIO-B's Income from Continuing Operations at 527100000.0 in Q1 2026, 720000000.0 in Q4 2025, and 341900000.0 in Q3 2025.